Conspectus
Nanoparticles are widely used in various biomedical
applications
as drug delivery carriers, imaging probes, single-molecule tracking/detection
probes, artificial chaperones for inhibiting protein aggregation,
and photodynamic therapy materials. One key parameter of these applications
is the ability of the nanoparticles to enter into the cell cytoplasm,
target different subcellular compartments, and control intracellular
processes. This is particularly the case because nanoparticles are
designed to interact with subcellular components for the required
biomedical performance. However, cells are protected from their surroundings
by the cell membrane, which exerts strict control over entry of foreign
materials. Thus, nanoparticles need to be designed appropriately so
that they can readily cross the cell membrane, target subcellular
compartments, and control intracellular processes.
In the past
few decades there have been great advancements in understanding
the principles of cellular uptake of foreign materials. In particular,
it has been shown that internalization of foreign materials (small
molecules, macromolecules, nanoparticles) is size-dependent: endocytotic
uptake of materials requires sizes greater than 10 nm, and materials
with sizes of 10–100 nm usually enter into cells by energy-dependent
endocytosis via biomembrane-coated vesicles. Direct access to the
cytosol is limited to very specific conditions, and endosomal escape
of material appears to be the most practical approach for intracellular
processing.
In this Account, we describe how cellular uptake
and intracellular
processing of nanoscale materials can be controlled by appropriate
design of size and surface chemistry. We first describe the cell membrane
structure and principles of cellular uptake of foreign materials followed
by their subcellular trafficking. Next, we discuss the designed surface
chemistry of a 5–50 nm particle that offers preferential lipid-raft/caveolae-mediated
endocytosis over clathrin-mediated endocytosis with minimum endosomal/lysosomal
trafficking or energy-independent direct cell membrane translocation
(without endocytosis) followed by cytosolic delivery without endosomal/lysosomal
trafficking. In particular, we emphasize that the zwitterionic–lipophilic
surface property of a nanoparticle offers preferential interaction
with the lipid raft region of the cell membrane followed by lipid
raft uptake, whereas a lower number of affinity biomolecules (<25)
on the nanoparticle surface offers caveolae/lipid-raft uptake, while
an arginine/guanidinium-terminated surface along with a size of <10
nm offers direct cell membrane translocation. Finally, we discuss
how nanoprobes can be designed by adapting these surface chemistry
and size preference principles so that they can readily enter into
the cell, label different subcellular compartments, and control intracellular
processes such as trafficking kinetics, exocytosis, autophagy, amyloid
aggregation, and clearance of toxic amyloid aggregates. The Account
ends with a Conclusions ...